why choose us

First received: May 19, 2023

Clinical Trial: Study of GBT021601 in Participants With Renal Impairment

Study Status: Completed

Recruit Status: RECRUITING

Condition: Renal Impairment

Study Type: INTERVENTIONAL


Official Title: A Phase I, Open-Label, Single-Dose, Non-Randomized, Parallel Group Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of GBT021601, an Oral Hemoglobin S Polymerization Inhibitor, in Adul

Brief Summary: Renal Impairment study of GBT021601.

Read more